G1 THERAPEUTICS IN

GTHX NASDAQ

ZombieStar

Notice how many times price has been rejected from the pink line -- and also notice how price is now above that resistance! EASY 100% gains from this point onward!

shkspr

NASDAQ:GTHX Possible Scenario: SHORT Evidence: Overbought RSI. Bearish Divergence * It's trading higher without any specific news, will drop soon. It's my opinion and could be wrong 100%

shulgin.alexander

long

CryptoFundManager

Insider buys: On Nov 18, 2020, Director, Glenn P Muir, purchased 50,000 shares in G1 Therapeutics (GTHX) for $675,000. It has a Market Cap of 544.056M G1 Therapeutics is a a clinical-stage biopharmaceutical company which engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with...

richymag101

Not sure about this one. Volatile as hell and weak (ish) buy signals. Analysts going mad for it tho... Any thoughts..?

dorfmanmaster

Earnings/News Co's lead cancer therapy, trilaciclib, gets FDA's "breakthrough therapy" status, which is meant to speed up review of drugs that treat life-threatening conditions GTHX says it will present new data on three of its drugs, including trilaciclib, at an upcoming conference in September FDA's move is a recognition that clinical data presented...

Will Wong

paints quite a different picture. The ABC is not quite complete yet. There is a potential drop from $21 to $12.

Trading_Places

@emarler this one fit the CODE

Trading_Places

@emarler

Trading_Places

this one is very interesting

RocketTickers

GTHX: g1 therapeutics inc 2018-03-05 06:00:22 Detected possible positive results in drug trial